Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures ...

Mustang Bio (MBIO) announced the pricing of a public offering of an aggregate of 2,657,807 shares of its common stock, Series C-1 warrants to ...

Bengaluru based WeWork India has officially set the stage for its public market debut, filing its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India. WeWork India is ...